Diabetes with moderate nonproliferative retinopathy and macular edema in the right eye is a complication of diabetes characterized by damage to the retinal blood vessels, leading to vision impairment. This condition is clinically significant as it can progress to severe vision loss if not managed appropriately. The ICD-10 Code E08.3311 facilitates accurate diagnosis, documentation, medical billing, and public health reporting, ensuring that healthcare providers can effectively track and manage this serious complication.
ICD-10 Code E08.3311 represents Diabetes with moderate nonproliferative retinopathy and macular edema in the right eye. This code is used when documenting cases where diabetes has led to retinal changes, specifically moderate nonproliferative retinopathy accompanied by macular edema. It is essential for accurate clinical documentation and billing, particularly in cases where patients require specialized eye care or treatment for diabetes-related complications.
Diabetes with moderate nonproliferative retinopathy and macular edema in the right eye is caused by chronic hyperglycemia, leading to damage to the retinal vasculature. This condition progresses through stages, and timely medical intervention is crucial to prevent further deterioration of vision. Patients may experience blurred vision or other visual disturbances, necessitating regular ophthalmologic evaluations.
ICD-10 Code E08.3311 is utilized in SOAP notes to document the patient's symptoms, assessment findings, and treatment plans related to diabetes with moderate nonproliferative retinopathy and macular edema in the right eye. This code is relevant in both acute and chronic care settings, ensuring comprehensive documentation of the patient's condition and facilitating appropriate management.
In SOAP notes, ICD-10 Code E08.3311 connects subjective patient-reported symptoms and objective clinical findings to a formal diagnosis of diabetes with moderate nonproliferative retinopathy and macular edema in the right eye. This code is essential for ensuring continuity of care, supporting accurate billing, and meeting electronic health record documentation standards.
Management of diabetes with moderate nonproliferative retinopathy and macular edema in the right eye requires prompt intervention to prevent vision loss. Treatment may include both pharmacologic and supportive measures.


HIPAA-compliant and designed with privacy in mind, your patient’s data is protected. Focus on care while we safeguard your information.
Learn moreICD-10 Code E08.3311 is critical in medical billing, particularly in hospital, emergency room, or specialty care settings for diabetes-related complications.
| CPT Code | Description |
|---|---|
| 92014 | Ophthalmological examination, established patient. |
| 67028 | Intravitreal injection of a pharmacologic agent. |
| 92250 | Fundus photography with interpretation and report. |
Common Questions About Using ICD-10 Code E08.3311 for Diabetes with moderate nonp rtnop with macular edema, r eye
What are the common symptoms of diabetes with moderate nonproliferative retinopathy?
Common symptoms include blurred vision, difficulty focusing, and visual disturbances. Patients may not experience symptoms until the condition progresses, making regular eye examinations essential.
How is the diagnosis of E08.3311 confirmed?
Diagnosis is confirmed through a comprehensive eye examination, including fundoscopic evaluation and optical coherence tomography, which reveal retinal changes associated with diabetes.
What treatment options are available for E08.3311?
Treatment options include optimizing blood glucose control, laser therapy, and intravitreal injections of anti-VEGF agents to manage macular edema.
How often should patients with E08.3311 be monitored?
Patients should be monitored regularly, typically every 3 to 6 months, depending on the severity of retinopathy and response to treatment.
Clinical Notes
SOAP notes
DAP notes
AI medical notes